Ładuje się......
Design, development and permeation studies of nebivolol hydrochloride from novel matrix type transdermal patches
BACKGROUND: Nebivolol hydrochloride is a third generation β-blocker with highly selective β(1)-receptor antagonist with antihypertensive properties having plasma half life of 10 h and 12% oral bioavailability. The aim of the present investigation was to form matrix type transdermal patches containin...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Medknow Publications & Media Pvt Ltd
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3814574/ https://ncbi.nlm.nih.gov/pubmed/24223377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.115813 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|